The post notes that much of the worry over semaglutide and cancer traces back to animal studies, and that a label warning differs from evidence of harm in people.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
After so-called Ozempic face and Ozempic hair loss, the post says another digestive symptom is getting attention and may point to something more than discomfort.
A new Annals of Internal Medicine podcast episode has Dr. Centor discussing where tirzepatide fits in type 2 diabetes treatment.
Loading…